This HTML5 document contains 42 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://dx.doi.org/10.1097/
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q81748954
rdf:type
wikibase:Item
schema:description
artículu científicu espublizáu en xunu de 2005 wetenschappelijk artikel article scientifique publié en 2005 scientific article published on 01 June 2005 наукова стаття, опублікована в червні 2005
p:P577
wds:Q81748954-0C707A8A-D35A-4AD4-84F5-1D054400C05A
wdt:P577
2005-06-01T00:00:00Z
p:P2093
wds:Q81748954-5B65E31A-59B0-42BD-837A-8DEAC95B30EA wds:Q81748954-81371043-3569-4A5C-A480-753F2687259A wds:Q81748954-F5B54136-852B-45D4-A830-12A546C65F1E wds:Q81748954-1BE573AA-A6BF-4BB5-99C0-584758590273
wdt:P2093
Lorenzo A Calò Andrea Semplicini Achille C Pessina Elisa Pagnin
rdfs:label
Bartter's and Gitelman's syndromes: a confirm in humans of the utility of Rho kinase inhibition for cardiovascular protection Bartter's and Gitelman's syndromes: a confirm in humans of the utility of Rho kinase inhibition for cardiovascular protection
skos:prefLabel
Bartter's and Gitelman's syndromes: a confirm in humans of the utility of Rho kinase inhibition for cardiovascular protection Bartter's and Gitelman's syndromes: a confirm in humans of the utility of Rho kinase inhibition for cardiovascular protection
schema:name
Bartter's and Gitelman's syndromes: a confirm in humans of the utility of Rho kinase inhibition for cardiovascular protection Bartter's and Gitelman's syndromes: a confirm in humans of the utility of Rho kinase inhibition for cardiovascular protection
p:P50
wds:Q81748954-2D8BE70C-EDD2-4614-94C9-C2970AC62172
wdt:P50
wd:Q57060108
p:P1476
wds:Q81748954-376DBA44-C82F-4295-995A-1FBF343D9695
wdt:P1476
Bartter's and Gitelman's syndromes: a confirm in humans of the utility of Rho kinase inhibition for cardiovascular protection
p:P304
wds:Q81748954-37E3A75A-0B7E-4302-A8CD-F0029F29E4D3
wdt:P304
1273-1275
p:P31
wds:Q81748954-4FACEAAB-4D68-4713-9305-F0935848A0F5
wdt:P31
wd:Q13442814
p:P698
wds:Q81748954-29A15C7A-E787-4270-AC85-5DCC17E3F4D6
wdtn:P698
n9:15894907
wdt:P698
15894907
p:P1433
wds:Q81748954-CAA70119-D368-4965-9BC0-198317272742
wdt:P1433
wd:Q6295318
p:P433
wds:Q81748954-6E8AF4AE-7646-435D-B83A-C6B5A3791813
p:P478
wds:Q81748954-A9AF9A9D-7F40-411A-945E-328A4DA92088
wdt:P433
6
wdt:P478
23
p:P356
wds:Q81748954-59336431-232C-4D27-9FE0-3CF586DB234A
wdtn:P356
n12:01.HJH.0000170394.99697.B3
wdt:P356
10.1097/01.HJH.0000170394.99697.B3